Lethal cervical abscess following bisphosphonate related osteonecrosis of the jaw |
| |
Affiliation: | 1. UMR MD2, AMU, Faculty of Medicine, Marseille, France;2. IRBA, France;3. Toulon University, France;4. Department of Hyperbaric Medicine, Sainte Marguerite Hospital, Marseille, France;5. Laboratoire de Biologie Moléculaire, Hôpital de la Conception, AP-HM, France;6. Department of Intensive Care, AP-HM, France;7. Department of Emergency Medicine, AP-HM, France;8. Department of Cardiology, Syncope Unit, Lavagna, Italy;9. Department of Cardiology, Timone University Hospital, Marseille, France;10. Laboratory of Biochemistry, Timone University Hospital, AP-HM, France |
| |
Abstract: | ContextBisphosphonates are common drugs used in the management of bone metabolic diseases. Because of their recently increased use, their adverse effects, especially bisphosphonate-related osteonecrosis of the jaw (BRONJ), are monitored more frequently. BRONJ is a critical challenge in craniofacial surgery and is difficult to treat. Its occurrence is either spontaneous or follows dentoalveolar surgery. Typical complications of BRONJ are painful exposed bone, pathological fractures, extra-oral fistula, and local infections.ObjectiveThe aim of this paper is to report a rare case of bacterial embolism in the internal jugular vein after a BRONJ-induced submandibular abscess resulting in bacterial sepsis, multi-organ failure syndrome, and death.Case illustrationA 59-year-old female patient developed severe BRONJ (stage II) with recurrent abscesses after oral osteoporosis therapy with alendronic acid. A subsequent submandibular abscess led to bacterial embolism of the left internal jugular vein, causing sepsis and death.DiscussionPrevention, early detection and management of BRONJ remain a crucial challenge in craniofacial clinical practice. Despite several therapeutic approaches described in the current literature, none have undergone bedside application.ConclusionConsidering this report of death after recurrent abscesses following BRONJ, the use of bisphosphonates should be carefully monitored in order to prevent such severe complications. |
| |
Keywords: | BRONJ Bisphosphonate Lethal cervical abscess Osteonecrosis Bacterial embolism |
本文献已被 ScienceDirect 等数据库收录! |
|